Wall Street Analysts Think Deciphera Pharmaceuticals, Inc. (DCPH) Could Surge 48.49%: Read This Before Placing a Bet

Deciphera Pharmaceuticals, Inc. (DCPH) closed the last trading session at $16.91, gaining 18% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $25.11 indicates a 48.5% upside potential.The average comprises nine short-term price targets ranging from a low of $14 to a high of $34, with a standard deviation of $6.01. While the lowest estimate indicates a decline of 17.2% from the curr ...